PIK3CB and cancer: Recent evidence suggests that PI3K signaling intersects with epithelial-mesenchymal transition (EMT) pathways to promote metastasis, while metabolic reprogramming—a hallmark of cancer—enables tumor cells to meet the bioenergetic demands of proliferation and invasion [5].